ASEAN Heart Journal

First online: 

Case Reports

Efficacy of Blood Pressure reduction of Losartan in selected Thai populations using Home Blood Pressure Monitoring and Office Blood Pressure measurements

Sarana Boonbaichaiyapruck, Wirunsiri Mekwiwatanawong, Kanuengnit Srisala,Montawatt Amnueypol, Prasit Keesukphan

22 September 2015

September 2015, 23:3

Case Reports

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

Reference Tools

References

1.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–23.

CrossRef    PubMed

 

2.Aekplakorn W et al. Prevalence and Managment of prehypertension and hypertension by geographic regions of Thailand: the Third National Health Examination Survey, 2004. Journal of Hypertension 2008; 26(2): 191–198.

CrossRef    PubMed

 

3.Celis H, Fagard RH. White-coat hypertension: a clinical review. Eur J Intern Med 2004;15:348–57.

CrossRef    PubMed

 

4.Myers MG. Current status of ambulatory blood pressure monitoring. Can J Cardiol 2004;20:1424–28.

PubMed

 

5.Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342–49.

CrossRef    PubMed

 

6.O’Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821–48.

CrossRef    PubMed

 

7.Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–72.

CrossRef    PubMed

 

8.National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. CG127. 2011 http://​guidance.​nice.​org.​uk/​CG127.

 

9.Mengden T et al. Self-measurement of blood pressure improves the accuracy and reduces the number of subjects in clinical trials. J Hypertens 1991; 9(suppl 6):S336–S337.

CrossRef

 

10.Sangwatanaroj S, Lertsuwunseri V. A Randomized Controlled Trial of the Effect of hypertensive educational program on Home Blood Pressure in Hypertensive Patients at King Chulalongkorn Hospital. Thai Heart J 2011;24:19–25.

 

11.Bobrie G et al. Duration of action of two ACE inhibitors using self blood pressure measurement. Thérapie 1997;52:187–93.

PubMed

 

12.Timmermann PB. Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res 1999; 22: 147–53.

CrossRef

 

13.Dahlöf B, Devereux RB, Kjeldsen SE, et al. for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.

CrossRef    PubMed

14.Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–69.

CrossRef    PubMed

 

.

.

Tel No: +603-7931 7900
Fax No: +603-7932 1400

 

 

D-13A-06, Menara Suezcap 1, KL Gateway,
No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari,
59200 Kuala Lumpur, Malaysia.

www.aseancardiology.org

ASEAN HEART Journal is Supported by Unrestricted Grant From 

Committed to therapeutic advances in cardiovascular research